Literature DB >> 20530264

Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener's granulomatosis.

Angelika Kuhl1, Brice Korkmaz, Bert Utecht, Andrea Kniepert, Ulf Schönermarck, Ulrich Specks, Dieter E Jenne.   

Abstract

Anti-neutrophil cytoplasmic Abs (cANCAs) against conformational epitopes of proteinase 3 (PR3) are regarded as an important pathogenic marker in Wegener's granulomatosis (WG). Although the three-dimensional structure of PR3 is known, binding sites of mAbs and cANCAs have not been mapped to date. Competitive binding and biosensor experiments suggested the existence of four nonoverlapping areas on the PR3 surface. In this paper, we present an approach to identify these discontinuous surface regions that cannot be mimicked by linear peptides. The very few surface substitutions found in closely related PR3 homologs from primates, which were further varied by the construction of functional human-gibbon hybrids, resulted in the differential loss of three Ab binding sites, two of which were mapped to the N-terminal beta-barrel and one to the linker segment connecting the N- and C-terminal barrels of PR3. The sera from WG patients differed in their binding to gibbon PR3 and the gibbon-human PR3 hybrid, and could be divided into two groups with similar or significantly reduced binding to gibbon PR3. Binding of almost all sera to PR3-alpha1-protease inhibitor (alpha1-PI) complexes was even more reduced and often absent, indicating that major antigenic determinants overlap with the active site surface on PR3 that associates with alpha1-PI. Similarly, the mouse mAbs CLB12.8 and 6A6 also did not react with gibbon PR3 and PR3-alpha1-PI complexes. Our data strongly suggest that cANCAs from WG patients at least in part recognize similar surface structures as do mouse mAbs and compete with the binding of alpha1-PI to PR3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530264     DOI: 10.4049/jimmunol.0903887

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Neutrophil serine proteases exert proteolytic activity on endothelial cells.

Authors:  Uwe Jerke; Daniel Perez Hernandez; Patrick Beaudette; Brice Korkmaz; Gunnar Dittmar; Ralph Kettritz
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

Review 3.  How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.

Authors:  R Kettritz
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

4.  Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.

Authors:  Francisco Silva; Amber M Hummel; Dieter E Jenne; Ulrich Specks
Journal:  J Autoimmun       Date:  2010-12       Impact factor: 7.094

5.  A monoclonal antibody (MCPR3-7) interfering with the activity of proteinase 3 by an allosteric mechanism.

Authors:  Lisa C Hinkofer; Susanne A I Seidel; Brice Korkmaz; Francisco Silva; Amber M Hummel; Dieter Braun; Dieter E Jenne; Ulrich Specks
Journal:  J Biol Chem       Date:  2013-07-31       Impact factor: 5.157

Review 6.  Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).

Authors:  Brice Korkmaz; Adam Lesner; Stephanie Letast; Yassir K Mahdi; Marie-Lise Jourdan; Sandrine Dallet-Choisy; Sylvain Marchand-Adam; Christine Kellenberger; Marie-Claude Viaud-Massuard; Dieter E Jenne; Francis Gauthier
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

7.  Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies.

Authors:  S M Ohlsson; S Ohlsson; D Söderberg; L Gunnarsson; Å Pettersson; M Segelmark; T Hellmark
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

8.  A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells.

Authors:  Hanxin Lu; Surender Khurana; Nitin Verma; Jody Manischewitz; Lisa King; John H Beigel; Hana Golding
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

9.  Characterization of the CD177 interaction with the ANCA antigen proteinase 3.

Authors:  Uwe Jerke; Stephen F Marino; Oliver Daumke; Ralph Kettritz
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

10.  4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.

Authors:  Jérôme Granel; Roxane Lemoine; Eric Morello; Yann Gallais; Julie Mariot; Marion Drapeau; Astrid Musnier; Anne Poupon; Martine Pugnière; Seda Seren; Dalila Nouar; Valérie Gouilleux-Gruart; Hervé Watier; Brice Korkmaz; Cyrille Hoarau
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.